Cargando…
Xenon Blocks Neuronal Injury Associated with Decompression
Despite state-of-the-art hyperbaric oxygen (HBO) treatment, about 30% of patients suffering neurologic decompression sickness (DCS) exhibit incomplete recovery. Since the mechanisms of neurologic DCS involve ischemic processes which result in excitotoxicity, it is likely that HBO in combination with...
Autores principales: | Blatteau, Jean-Eric, David, Hélène N., Vallée, Nicolas, Meckler, Cedric, Demaistre, Sebastien, Lambrechts, Kate, Risso, Jean-Jacques, Abraini, Jacques H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4606806/ https://www.ncbi.nlm.nih.gov/pubmed/26469983 http://dx.doi.org/10.1038/srep15093 |
Ejemplares similares
-
Tirofiban, a Glycoprotein IIb/IIIa Antagonist, Has a Protective Effect on Decompression Sickness in Rats: Is the Crosstalk Between Platelet and Leukocytes Essential?
por: Lambrechts, Kate, et al.
Publicado: (2018) -
Fluoxetine Protection in Decompression Sickness in Mice is Enhanced by Blocking TREK-1 Potassium Channel with the “spadin” Antidepressant
por: Vallée, Nicolas, et al.
Publicado: (2016) -
Xenon-helium gas mixture at equimolar concentration of 37.5% protects against oxygen and glucose deprivation-induced injury and inhibits tissue plasminogen activator
por: David, Hélène N., et al.
Publicado: (2017) -
Protective Effects of Fluoxetine on Decompression Sickness in Mice
por: Blatteau, Jean-Eric, et al.
Publicado: (2012) -
Thirty-five Day Fluoxetine Treatment Limits Sensory-Motor Deficit and Biochemical Disorders in a Rat Model of Decompression Sickness
por: Cosnard, Caroline, et al.
Publicado: (2017)